{"transactions":[{"id":4636914,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-07T19:45:26.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":17800,"price":7.09,"value":126202.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to\nthe vesting of RSUs on October 2, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":111921,"source":{"system":"sec-edgar","filing":"0001583098-26-000008","document":"wk-form4_1791402323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583098/000158309826000008/wk-form4_1791402323.xml","form_type":"4"}},{"id":793589,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:30:24.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793588,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":954,"price":8.96,"value":8547.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.80 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":129721,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793587,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":14527,"price":8.36,"value":121445.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.78 to $8.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":130675,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":793586,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:30:24.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":145202,"source":{"system":"sec-edgar","filing":"0001583098-26-000004","document":"wk-form4_1777930221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309826000004/wk-form4_1777930221.xml","form_type":"4"}},{"id":1001695,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T21:13:07.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":17801,"price":10.54,"value":187622.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":119858,"source":{"system":"sec-edgar","filing":"0001583098-25-000005","document":"wk-form4_1762981979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000158309825000005/wk-form4_1762981979.xml","form_type":"4"}},{"id":1067632,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T20:22:58.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":7844,"price":8.6475,"value":67830.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $8.6475."}],"balance_after":137659,"source":{"system":"sec-edgar","filing":"0001628280-25-040156","document":"wk-form4_1755116574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000162828025040156/wk-form4_1755116574.xml","form_type":"4"}},{"id":1160820,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:30:28.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000104","document":"wk-form4_1746232222.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000104/wk-form4_1746232222.xml","form_type":"4"}},{"id":1160819,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:30:28.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":145503,"source":{"system":"sec-edgar","filing":"0001367644-25-000104","document":"wk-form4_1746232222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764425000104/wk-form4_1746232222.xml","form_type":"4"}},{"id":1364828,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-14T21:18:57.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":10.91,"value":272750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2024, Mr. DeGolyer sold an aggregate of 25,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.83 - $11.05. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":111100,"source":{"system":"sec-edgar","filing":"0001367644-24-000186","document":"wk-form4_1731619131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000186/wk-form4_1731619131.xml","form_type":"4"}},{"id":1500061,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:41:02.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000087","document":"wk-form4_1716946853.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000087/wk-form4_1716946853.xml","form_type":"4"}},{"id":1500060,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:41:02.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":136100,"source":{"system":"sec-edgar","filing":"0001367644-24-000087","document":"wk-form4_1716946853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000087/wk-form4_1716946853.xml","form_type":"4"}},{"id":1764267,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T23:08:49.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":118670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":118670,"source":{"system":"sec-edgar","filing":"0001367644-23-000177","document":"wk-form4_1696547320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000177/wk-form4_1696547320.xml","form_type":"4"}},{"id":2156970,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":88000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 3,856 shares of Syros common stock for $7.07 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 3,856 shares of Syros common stock for $7.07 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":0.31,"expiration_date":"2032-08-23","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2156969,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":88000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 3,856 shares of Syros common stock for $25.10 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 3,856 shares of Syros common stock for $25.10 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":1.1,"expiration_date":"2031-08-23","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2156968,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,848 shares of Syros common stock for $27.84 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,848 shares of Syros common stock for $27.84 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2156967,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,191 shares of Syros common stock for $26.93 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,191 shares of Syros common stock for $26.93 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":1.18,"expiration_date":"2029-08-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2156966,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,191 shares of Syros common stock for $53.17 per share, after giving effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 2,191 shares of Syros common stock for $53.17 per share, after giving effect to the Reverse Split."}],"balance_after":0,"derivative":{"exercise_price":2.33,"expiration_date":"2028-08-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2156965,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-09-16T18:00:12.000Z","date":"2022-09-16","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This option was fully vested and assumed by Syros Pharmaceuticals, Inc. (\"Syros\") in its merger with the issuer and replaced with an option to purchase 4,382 shares of Syros common stock for $66.18 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the \"Reverse Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was fully vested and assumed by Syros Pharmaceuticals, Inc. (\"Syros\") in its merger with the issuer and replaced with an option to purchase 4,382 shares of Syros common stock for $66.18 per share, after giving effect to a 1-for-10 reverse stock split by Syros (the \"Reverse Split\")."}],"balance_after":0,"derivative":{"exercise_price":2.9,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-22-031344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322031344/doc4.xml","form_type":"4"}},{"id":2171494,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2022-08-29T06:30:38.000Z","date":"2022-08-24","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a one-year period in equal quarterly installments."}],"balance_after":88000,"derivative":{"exercise_price":0.31,"expiration_date":"2032-08-23","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-22-029940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924322029940/doc4.xml","form_type":"4"}},{"id":2589324,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - Option to buy","published_at":"2021-08-26T16:32:18.000Z","date":"2021-08-24","kind":"grant","acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over a one-year period in equal quarterly installments."}],"balance_after":88000,"derivative":{"exercise_price":1.1,"expiration_date":"2031-08-23","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0000899243-21-034260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924321034260/doc4.xml","form_type":"4"}},{"id":3048413,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - right to buy","published_at":"2020-08-24T17:41:36.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted as annual compensation for director service, vests over a one-year period in four equal quarterly installments."}],"balance_after":65000,"derivative":{"exercise_price":1.22,"expiration_date":"2020-08-20","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-20-023316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924320023316/doc4.xml","form_type":"4"}},{"id":3427882,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - right to buy","published_at":"2019-08-27T09:34:33.000Z","date":"2019-08-22","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted as annual compensation for director service, vests over a one-year period in four equal quarterly installments."}],"balance_after":50000,"derivative":{"exercise_price":1.18,"expiration_date":"2029-08-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-19-022499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924319022499/doc4.xml","form_type":"4"}},{"id":3831309,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - right to buy","published_at":"2018-08-28T17:01:46.000Z","date":"2018-08-26","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted as annual compensation for director service, vests over a one-year period in four equal quarterly installments."}],"balance_after":50000,"derivative":{"exercise_price":2.33,"expiration_date":"2028-08-26","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-18-023402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924318023402/doc4.xml","form_type":"4"}},{"id":3915047,"issuer":{"id":123718,"kind":"organization","name":"TYME TECHNOLOGIES, INC.","symbol":"TYME"},"owners":[{"id":49918,"kind":"person","name":"DeGolyer Donald W","position":1,"cik":"0001583098","reported_name":"DeGolyer Donald W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option - right to buy","published_at":"2018-05-29T20:34:10.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant vests over a one-year period in four equal quarterly installments."}],"balance_after":100000,"derivative":{"exercise_price":2.9,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-014359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1537917/000089924318014359/doc4.xml","form_type":"4"}}]}